- Oncology Medicine Manufacturer
- Hepatology Medicine Manufacturer
- Gastroenterology Medicine Manufacturer
- Nephrology Medicine Manufacturer
- ED (Erectile Dysfunction) Medicine Manufacturer
- Critical Care Medicine Manufacturer
- Focus Therapy
- HIV Medicine Manufacturer
- Rheumatology Medicine Manufacturer
- General Range
- Products List
- Dossiers List
- Generics Medicine
Description
Description
COMPOSITION: Each ml contains: Gemcitabine Hydrochloride eq. to Gemcitabine 38mg / Water for Injections q.s.
INDICATION:
- APRAGEM in combination with carboplatin is indicated for the treatment of patients with
advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based
therapy. - APRAGEM in combination with paclitaxel is indicated for the first-line treatment of patients with metastatic breast cancer after failure of prior anthracycline- containing adjuvant chemotherapy, unless anthracyclineswere clinically contraindicated
PACKING: 1 Vial Injection
Download Product PDF Attachment